– USA, CA – BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart, today announced the appointment of Raymond Cohen as chairman of its board of directors.
About Raymond W. Cohen
Raymond Cohen is an accredited public company director with over 40 years of experience in the life sciences industry. He currently serves as CEO and member of the board of directors of Axonics, Inc. (Nasdaq: AXNX), an Irvine, Calif.-based global medical technology company that he co-founded in 2013 and took public in October 2018. Axonics ranked No. 1 on the 2021 Deloitte Technology Fast 500 and the 2022 Financial Times ranking of the 500 fastest-growing companies in the Americas.
Mr. Cohen also serves as an independent director of SoniVie Ltd., a clinical-stage venture-backed company developing a denervation technology for uncontrolled hypertension. In late 2020, Mr. Cohen was named Entrepreneur of the Year by Ernst & Young for the Pacific Southwest United States.
“A total artificial heart is designed to take over the complete function of a patient’s failing heart and represents an advanced treatment option for people waiting on a heart transplant or those who do not qualify for certain reasons,” said Mr. Cohen. “The work done by BiVACOR over the past 15 years to develop the TAH system is impressive. I’ve spent much of my career in cardiology and consider it a privilege to join Dr. Timms and Dr. Cohn on this amazing journey.”
About BiVACOR
BiVACOR is a clinical-stage medical technology company developing the BiVACOR Total Artificial Heart, designed to be the first long-term therapy for patients with severe biventricular heart failure. The TAH is designed to replace the naive heart and address the global unmet need of patients with end-stage heart failure by providing a next-generation life-extending solution. BiVACOR was founded in 2008 by a team of internationally renowned biomedical engineers and cardiac surgeons, including founder and CTO Dr. Daniel Timms (Ph.D.) and CMO Dr. William Cohn (M.D.)
For more information: https://bivacor.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.